In re CMS Cancer Drug Reimbursement Policy
- Case Date: 2/10/2004
- Project Name: Health Care Project
On February 10, 2004, WLF filed comments with the Centers for Medicare and Medicaid Services (CMS) in opposition to the agency's national coverage reviews of four advanced anti-cancer drugs. CMS administers the Medicare program. The agency has announced that it is considering whether to deny reimbursement for off-label uses of key drugs for colorectal cancer and non-Hodgkin's lymphoma, which kill thousands of Americans annually. WLF, joined by the Abigail Alliance and the Lorenzen Cancer Foundation, argued that off-label prescribing is vital to cancer treatment and that CMS lacks the authority to deny coverage of these medicines.
|Awaiting CMS Action.|
More Information and Downloads:
2/10/2004: Download the Comments
Press Release: Medicare Agency Urged To Continue Covering Cancer Drugs